Biology Reference
In-Depth Information
Temin HM. 1993. Retrovirus variation and reverse transcription: abnormal strand transfers results
in retrovirus genetic variation. Proc Natl Acad Sci USA 280: 1949±1953.
Torre VS, Marozsan AJ, Albright JL, Collins KR, Hartley O, O¨ord RE, Quinones-Mateu ME,
Arts EJ. 2000. Variable sensitivity of CCR5-tropic human immunode®ciency virus type 1 iso-
lates to inhibition by RANTES analogs. J Virol 74: 4868±4876.
Verrier F, Borman AM, Brand D, Girard M. 1999. Role of the HIV type 1 glycoprotein 120 V3
loop in determining coreceptor usage. AIDS Res Hum Retroviruses 15: 731±743.
Wei X, Gosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoefer S, Nowak
MA, Hahn BH, Saag MS, Shaw GM. 1995. Viral dynamics in human immunode®ciency virus
type 1 infection. Nature 373: 117±122.
Willey RL, Theodore TS, Martin MA. 1994. Amino acid substitutions in the human immuno-
de®ciency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functionsl
properties of the virion envelope. J Virol 68: 4409±4419.
Wolinsky SM, Korber BTM, Neumann AU, Daniels M, Kunstman KJ, Whetsell AJ, Furtado MR,
Cao Y, Ho DD, Safrit JT, Koup RA. 1996. Adaptive evolution of human immunode®ciency
virus-type 1 during the ntural course of infection. Science 272: 537±542.
Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ru½ng N, Borsetti A, Cardoso AA, Desjardin E,
Newman W, Gerard C, Sodroski J. 1996. CD4-induced interaction of primary HIV-1 gp120
glycoproteins with the chemokine receptor CCR-5 [see comments]. Nature 384: 179±183.
Wyatt R, Moore J, Accola M, Desjardin E, Robinson J, Sodroski J. 1995. Involvement of the V1/
V2 variable loop structure in the exposure of human immunode®ciency virus type 1 gp120
epitopes induced by receptor binding. J Virol 69: 5723±5733.
Xiao L, Owen SM, Goldman I, Lal AA, deJong JJ, Goudsmit J, Lal RB. 1998. CCR5 coreceptor
usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct
global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5
usage. Virology 240: 83±92.
Yamaguchi Y, Gojobori T. 1997. Evolutionary mechanisms and population dynamics of the third
variable envelope region of HIV within single hosts. Proc Natl Acad Sci USA 94: 1264±1269.
Yamaguchi-Kabata Y, Gojobori T. 2000. Reevaluation of amino acid variability of the human
immunode®ciency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous
epitopes. J Virol 74: 4335±4350.
Yu H, Goodman MF. 1992. Comparison of HIV-1 and avian myeloblastosis virus reverse tran-
scriptase ®delity on RNA and DNA templates. J Biol Chem 267: 10888±10896.
Zhang W, Canziani G, Plugariu C, Wyatt R, Sodroski J, Sweet R, Kwong P, Hendrickson W,
Chaiken I. 1999. Conformational changes of gp120 in epitopes near the CCR5 binding site are
induced by CD4 and a CD4 miniprotein mimetic. Biochemistry 38: 9405±9416.
